The Golgi apparatus (GA) is a cellular organelle that participates in the packaging,
modification, and transport of proteins and lipids from the endoplasmic reticulum to be …

Immunometabolism within the tumor microenvironment is an appealing target for precision
therapy approaches in lung cancer. Interestingly, obesity confers an improved response to …

The value of lung adenocarcinoma (LUAD) subtypes and ground glass opacity (GGO) in
pathological stage IA invasive adenocarcinoma (IAC) has been poorly understood, and …

Background A significant proportion of patients with clinical stage IA non-small cell lung
cancer (NSCLC) experience will recurrence and decreased survival after surgery. This study …

Background Brain metastases (BMs) are common complications in patients with non-small
cell lung cancer (NSCLC). The purpose of this study was to investigate whether the …

Background: Epidermal growth factor receptor (EGFR) gene mutation is a known predictor of
the response to EGFR tyrosine kinase inhibitors. However, detecting EGFR mutations is a …

Early-stage lung cancer (stage IA) continues to pose an ongoing challenge as 5-year
disease free survival continues to be surprisingly low at approximately 64%[1]. Tapias and …

Background Mediastinal lymphadenopathies with high 18-fluorodeoxyglucose uptake in
patients previously operated on for lung cancer are alarming for recurrence and necessitate …

Background The relationship between systemic metabolism, immune function, and lung
cancer is complex and remains poorly defined. Seemingly paradoxically, overweight and …

Patients with preinvasive or invasive pulmonary ground‑glass opacity (GGO) often face
different clinical treatments and prognoses. The present study aimed to identify the …